These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12890128)

  • 1. Almotriptan versus rizatriptan in patients with migraine in Spain.
    Leira R; Dualde E; del Barrio H; Machuca M; López-Gil A;
    Headache; 2003; 43(7):734-41. PubMed ID: 12890128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of triptan tablet consumption per attack: a prospective study of migraineurs in Spain.
    Pascual J; Fité B; López-Gil A
    Headache; 2002 Feb; 42(2):93-8. PubMed ID: 12005301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient preference in migraine therapy. A randomized, open-label, crossover clinical trial of acute treatment of migraine with oral almotriptan and rizatriptan.
    Díez FI; Straube A; Zanchin G
    J Neurol; 2007 Feb; 254(2):242-9. PubMed ID: 17334957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migraine treatment outcomes with rizatriptan in triptan-naive patients: a naturalistic study.
    Solomon S; Frishberg B; Hu XH; Markson L; Berger M
    Clin Ther; 2001 Jun; 23(6):886-900. PubMed ID: 11440288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of almotriptan and rizatriptan in the treatment of acute migraine.
    Williams P; Reeder CE
    Clin Ther; 2003 Nov; 25(11):2903-19. PubMed ID: 14693315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine.
    McCormack PL; Foster RH
    Pharmacoeconomics; 2005; 23(12):1283-98. PubMed ID: 16336021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early intervention with almotriptan improves sustained pain-free response in acute migraine.
    Mathew NT
    Headache; 2003; 43(10):1075-9. PubMed ID: 14629242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine: analysis of return to function and patient preference.
    Pascual J; García-Moncó C; Roig C; Yusta Izquierdo A; López-Gil A;
    Headache; 2005 Oct; 45(9):1140-50. PubMed ID: 16178944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migraine treatment with rizatriptan and almotriptan: a crossover study.
    Ng-Mak DS; Hu XH; Bigal M
    Headache; 2009 May; 49(5):655-62. PubMed ID: 19456878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine.
    Loder E; Brandes JL; Silberstein S; Skobieranda F; Bohidar N; Wang L; Boyle D; Kolodny A; Guerra F; Santanello N; Johnson-Pratt L;
    Headache; 2001 Sep; 41(8):745-53. PubMed ID: 11576197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability and efficacy of almotriptan in the long-term treatment of migraine.
    Pascual J; Falk R; Docekal R; Prusinski A; Jelencsik J; Cabarrocas X; Segarra X; Luria X; Ferrer P
    Eur Neurol; 2001; 45(4):206-13. PubMed ID: 11385257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world experiences in migraine therapy with rizatriptan.
    Jamieson D; Cutrer FM; Goldstein J; Dayno J; Hu XH;
    Headache; 2003 Mar; 43(3):223-30. PubMed ID: 12603640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Rizatriptan Multiple Attack Study Group.
    Kramer MS; Matzura-Wolfe D; Polis A; Getson A; Amaraneni PG; Solbach MP; McHugh W; Feighner J; Silberstein S; Reines SA
    Neurology; 1998 Sep; 51(3):773-81. PubMed ID: 9748025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study.
    Krymchantowski AV; Barbosa JS
    Cephalalgia; 2002 May; 22(4):309-12. PubMed ID: 12100094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
    Visser WH; Winner P; Strohmaier K; Klipfel M; Peng Y; McCarroll K; Cady R; Lewis D; Nett R;
    Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
    Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW
    Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early treatment of migraine with rizatriptan: a placebo-controlled study.
    Mathew NT; Kailasam J; Meadors L
    Headache; 2004; 44(7):669-73. PubMed ID: 15209688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A long-term open-label study of oral almotriptan 12.5 mg for the treatment of acute migraine.
    Mathew NT;
    Headache; 2002 Jan; 42(1):32-40. PubMed ID: 12005273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of clinical, service, and cost outcomes of a conversion program of sumatriptan to rizatriptan ODT in primary care patients with migraine headaches.
    Gershovich OE; Billups SJ; Delate T; Hoffman CK; Carroll N
    J Manag Care Pharm; 2006 Apr; 12(3):246-53. PubMed ID: 16623609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further evaluation of rizatriptan in menstrual migraine: retrospective analysis of long-term data.
    Silberstein SD; Massiou H; McCarroll KA; Lines CR
    Headache; 2002 Oct; 42(9):917-23. PubMed ID: 12390621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.